Evidence map›Paper›PMID 42806233›Full record

ArticleUpdates in surgery2026

A retrospective multicenter study: postoperative prognostic value of the lymphocyte-C-reactive protein ratio combined with the Ki-67 index in gallbladder cancer.

Haijian Wang, Shuqing Xu, Jianwu Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haijian WangClinical Laboratory Department, The First Hospital of Putian City, No. 449, South Gate West Road, Chengxiang District, Putian City, 351100, Fujian Province, China.
Shuqing XuClinical Laboratory Department, Putian Hanjiang Hospital, Fujian, 351111, China.
Jianwu LiuHospital Infection Control Division, The First Hospital of Putian City, Fujian, 351100, China. liujianwufjpt@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the predictive value of the lymphocyte-to-C-reactive protein ratio (LCR) and Ki-67 index for postoperative prognosis in gallbladder cancer (GBC). This study included 180 patients with GBC who underwent radical resection, with 2-year postoperative recurrence-free survival (RFS) as the primary endpoint. Patients were divided into event (70 cases) and event-free (110 cases) groups depending on the occurrence of RFS. Ki-67 expression in tumor tissues was detected by immunohistochemistry. Univariate Cox regression and least absolute shrinkage and selection operator-Cox regression were adopted to explore the correlations of LCR and Ki-67 index with postoperative RFS, with Kaplan-Meier survival analysis and receiver operating characteristic curve analysis to evaluate their impacts on postoperative RFS and assess their predictive efficacy. The event group had lower LCR and higher Ki-67 index versus the event-free group. During follow-up, 70 RFS events (38.89%) and 30 OS events (16.67%) were observed. Low LCR and high Ki-67 index were linked to shorter RFS. Multivariate Cox analysis confirmed LCR (HR = 0.144, 95%CI: 0.064-0.325, P < 0.001) and Ki-67 index (HR = 1.058, 95%CI: 1.025-1.091, P < 0.001) to be independently correlated with RFS. Their combination showed moderate predictive performance for 2-year postoperative RFS events. GBC patients with postoperative RFS events present lower preoperative LCR and higher tumoral Ki-67 index. The two biomarkers are independently related to postoperative RFS, showing certain predictive value for 2-year postoperative RFS events. They are promising tools for postoperative risk stratification and adjuvant treatment decision-making in patients with GBC.

Indexed as

C-reactive proteinGallbladder cancerKi-67 indexLymphocyte-C-reactive protein ratioLymphocytesPredictive valueRecurrence-free survival

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.